Cargando…
Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study
SUMMARY: The effect of dopaminergic medication on the risk of hip/femur fractures is not clear. Our results showed a nearly twofold increased risk of hip/femur fractures in current dopaminergic drug users. Concomitant use of antidepressants further increased this risk. Fracture risk assessment may b...
Autores principales: | Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., de Vries, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106160/ https://www.ncbi.nlm.nih.gov/pubmed/20967420 http://dx.doi.org/10.1007/s00198-010-1455-3 |
Ejemplares similares
-
Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands
por: de Vries, F., et al.
Publicado: (2007) -
Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study
por: Pouwels, S., et al.
Publicado: (2009) -
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
por: Pouwels, S., et al.
Publicado: (2010) -
Use of anti-depressants and the risk of fracture of the hip or femur
por: van den Brand, M. W. M., et al.
Publicado: (2009) -
Use of anti-depressants and the risk of fracture of the hip or femur
por: van den Brand, M. W. M., et al.
Publicado: (2009)